Willem W. Overwijk
Division of Immunology
The Netherlands Cancer Institute
1105 AZ Amsterdam
Netherlands
Name/email consistency: high
- Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant. Overwijk, W.W., de Visser, K.E., Tirion, F.H., de Jong, L.A., Pols, T.W., van der Velden, Y.U., van den Boorn, J.G., Keller, A.M., Buurman, W.A., Theoret, M.R., Blom, B., Restifo, N.P., Kruisbeek, A.M., Kastelein, R.A., Haanen, J.B. J. Immunol. (2006)
- Breaking tolerance in cancer immunotherapy: time to ACT. Overwijk, W.W. Curr. Opin. Immunol. (2005)